Hwang Jung Hwan, Kim Dong Wook, Suh Jae Mi, Kim Ho, Song Jung Hun, Hwang Eun Suk, Park Ki Cheol, Chung Hyo Kyun, Kim Jin Man, Lee Tae-Hoon, Yu Dae-Yeul, Shong Minho
Laboratory of Endocrine Cell Biology, Department of Internal Medicine, Chungnam National University College of Medicine, 640 Daesadong Chungku, Daejeon 301-721, Korea.
Mol Endocrinol. 2003 Jun;17(6):1155-66. doi: 10.1210/me.2002-0401. Epub 2003 Mar 13.
Thyroid papillary carcinomas are characterized by RET/PTC (rearranged in transformation/papillary thyroid carcinoma) rearrangements that result in fusion of the tyrosine kinase domain of the RET receptor to the N-terminal sequences encoded by heterologous genes. This thyroid-specific rearrangement causes aberrant expression of RET/PTC and results in constitutive ligand-independent activation of RET kinase. However, it is unclear how RET/PTC activates the specific signaling pathways for cellular transformation. In this study, we show that RET/PTC associates with signal transducer and activator of transcription 3 (STAT3) and activates it by the specific phosphorylation of the tyrosine 705 residue. Activation of STAT3 requires the intrinsic kinase activity of RET/PTC; Janus tyrosine kinase and c-Src kinase are not involved in the RET/PTC-mediated activation of STAT3. RET/PTC-induced activation of STAT3 induces the STAT3-responsive genes, vascular endothelial growth factor, cyclin D1, and intercellular adhesion molecule 1. In addition, RET/PTC-mediated cellular transformation and proliferation of transformed cells require tyrosine 705 phosphorylation of STAT3 in NIH3T3 cells. We conclude that STAT3 activation by the RET/PTC tyrosine kinase is one of the critical signaling pathways for the regulation of specific genes, such as cyclin D1, vascular endothelial growth factor, and intercellular adhesion molecule 1, and for cellular transformation.
甲状腺乳头状癌的特征是存在RET/PTC(转染重排/甲状腺乳头状癌)重排,这种重排导致RET受体的酪氨酸激酶结构域与异源基因编码的N端序列融合。这种甲状腺特异性重排导致RET/PTC异常表达,并导致RET激酶的组成型非配体依赖性激活。然而,尚不清楚RET/PTC如何激活细胞转化的特定信号通路。在本研究中,我们发现RET/PTC与信号转导和转录激活因子3(STAT3)结合,并通过酪氨酸705残基的特异性磷酸化激活它。STAT3的激活需要RET/PTC的内在激酶活性;Janus酪氨酸激酶和c-Src激酶不参与RET/PTC介导的STAT3激活。RET/PTC诱导的STAT3激活诱导STAT3反应性基因、血管内皮生长因子、细胞周期蛋白D1和细胞间黏附分子1的表达。此外,RET/PTC介导的细胞转化和转化细胞的增殖需要NIH3T3细胞中STAT3的酪氨酸705磷酸化。我们得出结论,RET/PTC酪氨酸激酶激活STAT3是调节细胞周期蛋白D1、血管内皮生长因子和细胞间黏附分子1等特定基因以及细胞转化的关键信号通路之一。